In Situ Sensor Advancements for Osteoporosis Prevention, Diagnosis, and Treatment.
Osteoporosis is still a serious issue in healthcare, and will continue to increase due to the aging and growth of the population. Early diagnosis is the key to successfully treating many diseases. The earlier the osteoporosis is diagnosed, the more quickly people can take action to stop bone deterioration. Motivated by this, researchers and companies have begun developing smart in situ bone sensors in order to dramatically help people to monitor their bone mass density (BMD), bone strain or bone turnover markers (BTMs); promptly track early signs of osteoporosis; and even monitor the healing process following surgery or antiresorptive therapy. This paper focuses on the latest advancements in the field of bone biosensing materials and sensor technologies and how they can help now and in the future to detect disease and monitor bone health.
Department of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA.
Luting
L
Liu
Department of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA. th.webster@neu.edu.|Center of Excellence for Advanced Materials Research, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. th.webster@neu.edu.|Wenzhou Institute of Biomaterials and Engineering, Wenzhou Medical University, Wenzhou, 325000, China. th.webster@neu.edu.
Thomas J
TJ
Webster
D015374:Biosensing Techniques / Q000379:methods*; D015519:Bone Density; D016723:Bone Remodeling; D006801:Humans; D036103:Nanotechnology; D010024:Osteoporosis / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control
Biomarker; Biosensor; Bone; Nanotechnology; Osteoporosis